Today’s PR was good, but it doesn’t much impac
Post# of 145222
What we need is the TNBC trial to happen and a deal on the prostate test to close. Or maybe even a deal for combo and/or mono therapy. CYDY needs cash.
Hanging around this .40 is worrisome because if CYDY raises funds at this range, we’re going to tank to .30. I understand the long term play, I’ve been here since 2015, but at some point we as investors have to say mercy.
I have faith the NP will pulp through, and the RPs cancer knowledge will make Leronlimab a household name for cancer, but at what cost to us.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)